Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS
Thiogenesis Therapeutics, Corp. a clinical-stage biotechnology company developing disulfides that are precursors to thiol-active compounds and that have the potential to treat unmet pediatric...
San Diego United States Patrice Rioux Vince Stanton Jr Venture Exchange Company Scientific Advisory Board
Source: marketscreener.com